Login / Signup

Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke.

Robert HemmingsArmin Koch
Published in: Pharmaceutical statistics (2019)
Keyphrases
  • randomized controlled trial
  • clinical trial
  • study protocol
  • open label
  • data analysis